USFDA issues warning letter to Intas Pharma for lapses at Sanand plant

The US health regulator has pulled up Intas Pharmaceuticals for manufacturing lapses, including failure of its quality control unit to ensure CGMP compliance, at its Sanand-based manufacturing plant. In a warning letter dated July 28, 2023, the US Food and Drug Administration (USFDA) pointed out various manufacturing lapses at the plant. “This… Continue reading USFDA issues warning letter to Intas Pharma for lapses at Sanand plant

NFRA slaps 10-year ban, imposes Rs 5 lakh fine on auditor for lapses

The National Financial Reporting Authority on Thursday slapped a penalty of Rs 5 lakh and a 10-year ban on an auditor for alleged professional misconduct in the audit of Bartronics India Ltd for 2013-15. Bartronics India Ltd (BIL) is listed on BSE and NSE. In its order, NFRA said that it had… Continue reading NFRA slaps 10-year ban, imposes Rs 5 lakh fine on auditor for lapses

Man Industries settles forensic audit disclosure lapses case with Sebi

Man Industries (India) Ltd on Monday settled with capital markets regulator Sebi a case concerning alleged delayed and inadequate disclosure regarding the initiation of a forensic audit. The matter was settled after the company paid Rs 8.79 lakh towards the settlement amount, according to an order passed by the Securities and Exchange Board… Continue reading Man Industries settles forensic audit disclosure lapses case with Sebi

State found lapses at Inglewood hospital

An Inglewood hospital violated federal requirements in ways that could jeopardize patients, including by failing to properly assess and treat birthing patients to reduce the risk of blood clots, a state review found. Centinela Hospital Medical Center repeatedly failed to take steps to prevent patients from suffering potentially deadly clots, which can include using compression… Continue reading State found lapses at Inglewood hospital